AI
IDYA icon

Alphabet Inc’s IDEAYA Biosciences IDYA Stock Holding History

Alphabet Inc’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-753,187
Closed -$10.4M – 50
2022
Q2 		$10.4M Hold
753,187
– – 0.56% 23
2022
Q1 		$8.43M Hold
753,187
– – 0.27% 32
2021
Q4 		$17.8M Hold
753,187
– – 0.43% 29
2021
Q3 		$19.2M Hold
753,187
– – 0.46% 22
2021
Q2 		$15.8M Hold
753,187
– – 0.32% 21
2021
Q1 		$17.7M Hold
753,187
– – 0.71% 18
2020
Q4 		$10.5M Hold
753,187
– – 0.51% 20
2020
Q3 		$9.46M Hold
753,187
– – 0.44% 13
2020
Q2 		$10.7M Hold
753,187
– – 0.49% 15
2020
Q1 		$3.1M Hold
753,187
– – 0.2% 22
2019
Q4 		$5.65M Hold
753,187
– – 0.34% 20
2019
Q3 		$6.78M Hold
753,187
– – 0.2% 17
2019
Q2 		$7.5M Buy
+753,187
New +$8.19M 0.14% 18

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alphabet Inc's IDYA Position: Q3 2022 in Review

Alphabet Inc sold out of IDEAYA Biosciences (IDYA) in Q3 2022, closing a stake of 753,187 shares — an estimated $10.4M sold.

Alphabet Inc first reported a position in IDYA in Q2 2019 and held it in 13 quarters. The position peaked at $19.2M in Q3 2021. 112 funds tracked by Wall St. Rank hold IDYA as of Q3 2022.

  • Alphabet Inc reported no remaining IDEAYA Biosciences position as of Q3 2022 after selling out during the quarter.
  • Alphabet Inc sold 753,187 IDEAYA Biosciences shares in Q3 2022, an estimated $10.4M.
  • Alphabet Inc first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 13 quarters.
  • Alphabet Inc's IDEAYA Biosciences position peaked at $19.2M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2022.

Based on Alphabet Inc's 13F filing for Q3 2022, filed 15 Nov 2022.